This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Joerg Moelleken: Innovator in Antibody Development
Introduction
Joerg Moelleken is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Joerg Moelleken holds a patent for an "Antibody that Binds to VEGF-A and ANG2 and Methods of Use." This patent represents a crucial advancement in therapeutic approaches for various diseases, showcasing his expertise in antibody technology. He has 1 patent to his name, reflecting his commitment to innovation in the medical field.
Career Highlights
Moelleken is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects. His work is instrumental in advancing the understanding and treatment of diseases.
Collaborations
Throughout his career, Joerg has worked alongside talented colleagues, including Sabine Lmhof-Jung and Christian Schantz. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Joerg Moelleken is a dedicated inventor whose work in antibody development has the potential to transform therapeutic strategies. His contributions to Hoffmann-La Roche Inc. and the biotechnology sector highlight his importance in the ongoing quest for medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile